We thus tested this hypothesis by evaluating the effects of chronic and acute NRG1 treatment on the systemic glucose metabolism regulation in db/db mice, an animal model of type 2 diabetes. The gene discussed is NRG1; the disease is type 2 diabetes mellitus.